Literature DB >> 33776654

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice.

Hao Gu1,2, Xiuli Yang1,2, Xiaobo Mao1,2, Enquan Xu1,2, Chen Qi1,2, Haibo Wang1,2, Saurav Brahmachari1,2, Bethany York1,2, Manjari Sriparna1,2, Amanda Li1,2, Michael Chang1,2, Pavan Patel1,2, Valina L Dawson1,2,3,4,5, Ted M Dawson1,2,3,4,5.   

Abstract

Aggregation of misfolded α-synuclein (α-syn) is the major component of Lewy bodies and neurites in Parkinson's disease (PD) and related α-synucleinopathies. Some α-syn mutations (e.g., A53T) in familial PD recapitulate the α-syn pathology in transgenic mice, which supports the importance of pathologic α-syn in driving the pathogenesis of α-synucleinopathies. Lymphocyte activation gene 3 (Lag3) is a receptor of α-syn fibrils facilitating pathologic α-syn spread; however, the role of Lag3 in mediating the pathogenesis in α-syn transgenic mice is not clear. Here, we report that depletion of Lag3 in human α-syn A53T transgenic (hA53T) mice significantly reduces the level of detergent-insoluble α-syn aggregates and phosphorylated ser129 α-syn, and inhibits activation of microglia and astrocytes. The absence of Lag3 significantly delays disease progression and reduces the behavioral deficits in hA53T transgenic mice leading to prolonged survival. Taken together, these results show that Lag3 contributes to the pathogenesis in the α-syn A53T transgenic mouse model.
Copyright © 2021 Gu, Yang, Mao, Xu, Qi, Wang, Brahmachari, York, Sriparna, Li, Chang, Patel, Dawson and Dawson.

Entities:  

Keywords:  Lag3; Parkinson’ disease; aggregation; α-synuclein; α-synucleinopathy

Year:  2021        PMID: 33776654      PMCID: PMC7987675          DOI: 10.3389/fncel.2021.656426

Source DB:  PubMed          Journal:  Front Cell Neurosci        ISSN: 1662-5102            Impact factor:   5.505


  31 in total

1.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

Review 2.  Genetic animal models of Parkinson's disease.

Authors:  Ted M Dawson; Han Seok Ko; Valina L Dawson
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

Review 3.  Microglia and astrocyte dysfunction in parkinson's disease.

Authors:  Tae-In Kam; Jared T Hinkle; Ted M Dawson; Valina L Dawson
Journal:  Neurobiol Dis       Date:  2020-07-28       Impact factor: 5.996

Review 4.  Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.

Authors:  Ana C Anderson; Nicole Joller; Vijay K Kuchroo
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

5.  Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.

Authors:  Michael K Lee; Wanda Stirling; Yanqun Xu; Xueying Xu; Dike Qui; Allen S Mandir; Ted M Dawson; Neal G Copeland; Nancy A Jenkins; Don L Price
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

6.  New tools for studying microglia in the mouse and human CNS.

Authors:  Mariko L Bennett; F Chris Bennett; Shane A Liddelow; Bahareh Ajami; Jennifer L Zamanian; Nathaniel B Fernhoff; Sara B Mulinyawe; Christopher J Bohlen; Aykezar Adil; Andrew Tucker; Irving L Weissman; Edward F Chang; Gordon Li; Gerald A Grant; Melanie G Hayden Gephart; Ben A Barres
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

7.  Markers of microglia in post-mortem brain samples from patients with Alzheimer's disease: a systematic review.

Authors:  K E Hopperton; D Mohammad; M O Trépanier; V Giuliano; R P Bazinet
Journal:  Mol Psychiatry       Date:  2017-12-12       Impact factor: 15.992

Review 8.  Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease.

Authors:  Géraldine Gelders; Veerle Baekelandt; Anke Van der Perren
Journal:  J Immunol Res       Date:  2018-04-16       Impact factor: 4.818

9.  The microglial sensome revealed by direct RNA sequencing.

Authors:  Suzanne E Hickman; Nathan D Kingery; Toshiro K Ohsumi; Mark L Borowsky; Li-chong Wang; Terry K Means; Joseph El Khoury
Journal:  Nat Neurosci       Date:  2013-10-27       Impact factor: 24.884

View more
  6 in total

1.  α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice.

Authors:  Yemima R Butler; Yuqing Liu; Ramhari Kumbhar; Peiran Zhao; Kundlik Gadhave; Ning Wang; Yanmei Li; Xiaobo Mao; Wenjing Wang
Journal:  Nat Commun       Date:  2022-07-19       Impact factor: 17.694

2.  Evidence of Inflammation in Parkinson's Disease and Its Contribution to Synucleinopathy.

Authors:  Thuy Thi Lai; Yun Joong Kim; Hyeo-Il Ma; Young Eun Kim
Journal:  J Mov Disord       Date:  2021-11-03

Review 3.  Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity.

Authors:  Stephanie E A Burnell; Lorenzo Capitani; Bruce J MacLachlan; Georgina H Mason; Awen M Gallimore; Andrew Godkin
Journal:  Immunother Adv       Date:  2021-12-20

Review 4.  α-Synuclein Conformational Plasticity: Physiologic States, Pathologic Strains, and Biotechnological Applications.

Authors:  Amanda Li; Cyrus Rastegar; Xiaobo Mao
Journal:  Biomolecules       Date:  2022-07-17

5.  LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathies.

Authors:  Marc Emmenegger; Elena De Cecco; Marian Hruska-Plochan; Timo Eninger; Matthias M Schneider; Melanie Barth; Elena Tantardini; Pierre de Rossi; Mehtap Bacioglu; Rebekah G Langston; Alice Kaganovich; Nora Bengoa-Vergniory; Andrès Gonzalez-Guerra; Merve Avar; Daniel Heinzer; Regina Reimann; Lisa M Häsler; Therese W Herling; Naunehal S Matharu; Natalie Landeck; Kelvin Luk; Ronald Melki; Philipp J Kahle; Simone Hornemann; Tuomas P J Knowles; Mark R Cookson; Magdalini Polymenidou; Mathias Jucker; Adriano Aguzzi
Journal:  EMBO Mol Med       Date:  2021-07-26       Impact factor: 12.137

6.  Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson's disease.

Authors:  Shengnan Zhang; Yu-Qing Liu; Chunyu Jia; Yeh-Jun Lim; Guoqin Feng; Enquan Xu; Houfang Long; Yasuyoshi Kimura; Youqi Tao; Chunyu Zhao; Chuchu Wang; Zhenying Liu; Jin-Jian Hu; Meng-Rong Ma; Zhijun Liu; Lin Jiang; Dan Li; Renxiao Wang; Valina L Dawson; Ted M Dawson; Yan-Mei Li; Xiaobo Mao; Cong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-29       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.